Teal Health, headquartered in San Francisco (USA), has achieved a significant milestone in its mission to improve cervical cancer screening options. The company has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA) for its at-home self-collect cervical cancer screening device, the Teal Wand. This designation follows the successful completion of Teal Health’s clinical trial. The trial surpassed…
Bayer and Hologic have announced a collaboration to introduce a solution for contrast-enhanced mammography (CEM), a technique enhancing breast tissue visualization for improved breast cancer detection and treatment guidance. Contrast-enhanced mammography is a breast imaging modality aiding in breast cancer diagnosis. By integrating Hologic’s mammography technologies with Bayer’s contrast delivery system, the MEDRAD Stellant FLEX Computed Tomography (CT) Injection System, the collaboration…
Roche has achieved CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, a companion diagnostic designed to identify metastatic breast cancer patients expressing low levels of HER2. This approval enables the consideration of ENHERTU (trastuzumab deruxtecan) as a targeted treatment for these patients. Metastatic breast cancer (mBC) affects a significant portion of patients, with approximately half expressing low…
MOLLI Surgical, a company active in surgical innovation, has unveiled its latest breakthrough: OncoPen, a novel surgical tool designed to enhance precision and confidence in breast cancer surgery. The launch of OncoPen represents a significant advancement in minimally invasive surgery and promises improved outcomes for patients battling breast cancer. The OncoPen is seamlessly integrated with the MOLLI 2 System, providing surgeons with…
Meijer, a retailer serving customers across the Midwest, has unveiled a new offering in its intimates section: AnaOno x Tranquil & True, a collaborative collection featuring mastectomy bras designed to provide comfort and style for individuals who have undergone breast surgeries. This partnership brings together AnaOno, a leading mastectomy bra brand, and Tranquil & True, Meijer’s intimate apparel label, to offer inclusive…
New promising advancements in breast cancer detection have been unveiled by scientists at Nottingham Trent University (NTU). The research team is pioneering the development of a revolutionary device designed to fit discreetly within a bra, offering potential breakthroughs in tumor monitoring. According to The Guardian, this innovative device promises to provide a non-invasive method for detecting tumor growth, empowering patients to monitor…
23andMe has recently unveiled an initiative aimed at offering deeper insights into the risk of developing breast cancer. The company’s new genetic reports bring forth a new approach to cancer risk prediction, particularly focusing on breast, colorectal, and prostate cancer. Recent studies have underscored a concerning trend: a notable increase in cancer diagnoses among younger individuals. Federal data from the US indicates…
DeepLook Medical has recently achieved a significant milestone by receiving regulatory approval in the United Kingdom for its DL Precise software. DL Precise, an advanced visual enhancement software, distinguishes itself through its ability to uncover hidden data within medical images. Utilizing a sophisticated shape-recognition technique, the software provides clear, segmented, and measured views of target masses, enhancing the speed, accuracy, and consistency…
